Arrowhead Research Corp Heads Higher After Breakout

After a nice three-week rally, the stock market has stalled for about the last week. The S&P 500 has been stuck within 10 points of 2000, a psychologically important level.

Most of the biotech industry has been doing the same. The iShares NASDAQ Biotechnology Index ETF IBB hit a new all-time high earlier this week, yet still sits near the same $275 mark it's been at for the last week.

There have been a few biotech stocks, however, that made significant moves this week.

Related Link: Top 5 Performing Biotech Stocks of 2014

The company: Arrowhead Research Corp

Ticker Symbol: ARWR

Sector: Healthcare

Industry: Biotechnology

Arrowhead Research develops targeted RNAi therapeutics in the United States.

The company’s platform technologies include Dynamic Polyconjugate platform, a RNA delivery system that addresses multiple organ systems and cell types, promotes multi-log gene knockdown and induces endosomal escape.

Take a look at the one-year chart of Arrowhead, with added notations:

Arrowhead hit a rough patch back in March and April, finally bottoming around $9 towards the beginning on May.

Arrowhead has since formed a good representation of a double bottom price pattern, with the seco^nd bottom occurring in August.

Related Link: ISIS Pharmaceuticals Finally Breaks Out

Arrowhead on Wednesday broke through the $15.50-16.00 resistance zone that had been created by the double bottom pattern, thus confirming the pattern.

The stock closed at $16.27.

Always remember to use protective stops to be around for the next trade. Capital preservation is always key.